GRANULES vs NATCOPHARM vs BIOCON vs ALKEM: which stock is better?
Granules India Limited (GRANULES) has the highest StockLens rating in this group at 7.5/10 (Good).
| Metric | GRANULES | NATCOPHARM | BIOCON | ALKEM |
|---|---|---|---|---|
| Overall rating | 7.5/10 (Good) | 4.9/10 (Average) | 2.4/10 (Poor) | 5.8/10 (Average) |
| Long-term view | Strong long-term candidate | Neutral (watchlist) | Avoid | Neutral (watchlist) |
| Trade bias | Strong long | Strong short | Strong short | Short bias |
| Share price | ₹797.50 | ₹820.60 | ₹361.95 | ₹5,222.50 |
| Market cap | ₹21,754 Cr | ₹16,098 Cr | ₹59,279 Cr | ₹62,443 Cr |
| P/E | 27.9 | 17.9 | 121.5 | 30.2 |
| Return on equity | 13.5% | 9.0% | 1.0% | 14.2% |
| Debt / equity | 0.17 | 0.11 | 0.42 | 0.15 |
| Revenue growth (YoY) | +20.3% | -29.0% | +2.2% | +13.8% |
| 1-year return | +45.0% | +3.5% | -6.0% | -8.0% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.